VJHemOnc is committed to improving our service to you

Share this video  

VJHemOnc is committed to improving our service to you

EBMT 2021 | Curative options for X-CGD

Tayfun Güngör, MD, University Children’s Hospital Zurich, Zurich, Switzerland, shares a summary of his talk comparing curative options for X-linked chronic granulomatous disease (X-CGD). Dr Güngör describes the use of gene therapy for patients who do not have matched donors and compares results with those from patients who received allogeneic stem cell transplantation using alternative donors. This interview took place during the 47th Annual Meeting of the European Group for Blood and Marrow Transplantation (EBMT) 2021.

Disclosures

Dr Tayfun Güngör, MD, has participated in advisory boards for Jazz Pharmaceuticals and Novartis.

Sign-up for our Newsletter!

Keep up to date with all the latest news with our monthly newsletter